Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Jaffray, Ellis

Class:Id	Person:2997658
_displayName	Jaffray, Ellis
_timestamp	2013-01-23 21:25:40
created	[InstanceEdit:2997618] May, B, 2013-01-23
firstname	Ellis
initial	E
surname	Jaffray
(author)	[LiteratureReference:2997562] The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation [LiteratureReference:3000428] A proteomic study of SUMO-2 target proteins [LiteratureReference:3000459] Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection [LiteratureReference:3214989] Post-translational modification by SUMO [LiteratureReference:3788647] SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression [LiteratureReference:3788656] SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression [LiteratureReference:4090327] Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification [LiteratureReference:4090415] Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity [LiteratureReference:4551753] Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction [LiteratureReference:4641339] Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity List all 11 refering instances
[Change default viewing format]

No pathways have been reviewed or authored by Jaffray, Ellis (2997658)